GeneDx Cost Of Revenue from 2010 to 2025
| WGSWW Stock | 0.22 0.01 4.76% |
Cost Of Revenue | First Reported 2010-12-31 | Previous Quarter 111.1 M | Current Value 137.6 M | Quarterly Volatility 45.9 M |
Check GeneDx Holdings financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among GeneDx Holdings' main balance sheet or income statement drivers, such as Interest Income of 3.1 M, Depreciation And Amortization of 31.3 M or Selling General Administrative of 142 M, as well as many indicators such as Price To Sales Ratio of 3.98, Dividend Yield of 0.0 or PTB Ratio of 8.85. GeneDx financial statements analysis is a perfect complement when working with GeneDx Holdings Valuation or Volatility modules.
GeneDx | Cost Of Revenue |
Latest GeneDx Holdings' Cost Of Revenue Growth Pattern
Below is the plot of the Cost Of Revenue of GeneDx Holdings Corp over the last few years. Cost of Revenue is found on GeneDx Holdings Corp income statement and represents the costs associated with goods and services GeneDx Holdings provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities. It is GeneDx Holdings' Cost Of Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in GeneDx Holdings' overall financial position and show how it may be relating to other accounts over time.
| Cost Of Revenue | 10 Years Trend |
|
Cost Of Revenue |
| Timeline |
GeneDx Cost Of Revenue Regression Statistics
| Arithmetic Mean | 136,875,858 | |
| Geometric Mean | 131,494,920 | |
| Coefficient Of Variation | 33.56 | |
| Mean Deviation | 32,586,430 | |
| Median | 113,389,000 | |
| Standard Deviation | 45,936,308 | |
| Sample Variance | 2110.1T | |
| Range | 150.4M | |
| R-Value | 0.47 | |
| Mean Square Error | 1757.2T | |
| R-Squared | 0.22 | |
| Significance | 0.06 | |
| Slope | 4,553,874 | |
| Total Sum of Squares | 31652.2T |
GeneDx Cost Of Revenue History
About GeneDx Holdings Financial Statements
GeneDx Holdings investors use historical fundamental indicators, such as GeneDx Holdings' Cost Of Revenue, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in GeneDx Holdings. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Cost Of Revenue | 111.1 M | 137.6 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Additional Tools for GeneDx Stock Analysis
When running GeneDx Holdings' price analysis, check to measure GeneDx Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeneDx Holdings is operating at the current time. Most of GeneDx Holdings' value examination focuses on studying past and present price action to predict the probability of GeneDx Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeneDx Holdings' price. Additionally, you may evaluate how the addition of GeneDx Holdings to your portfolios can decrease your overall portfolio volatility.